InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Citius Pharmaceuticals, Inc.

CTXR Clue Score33
United States Fiscal year ends September CIK 0001506251
$0.49 -1.32% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.49 −75.48% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 6 Jul 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.1Operating income−10.0Net income−10.4Fiscal year 2018Revenue0.1 +50.0%Operating income−13.8Net income−12.5Fiscal year 2019Revenue0.1 +20.0%Operating income−15.6Net income−15.6Fiscal year 2020Revenue0.1 +0.0%Operating income−17.7Net income−17.5Fiscal year 2021Revenue0.1 +0.0%Operating income−23.5Net income−23.1EPS, diluted−0.23Fiscal year 2022Revenue0.1 +0.0%Operating income−33.3Net income−33.6EPS, diluted−0.23Fiscal year 2023Operating income−36.7Net income−32.5EPS, diluted−5.57Fiscal year 2024Operating income−42.0Net income−39.4EPS, diluted−5.97Fiscal year 2025Operating income−38.5Net income−39.7EPS, diluted−3.38
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.1 0.1 0.1 0.1 0.1 n/a n/a n/a
Growth +50.0% +20.0% +0.0% +0.0% +0.0%
Operating income −10.0 −13.8 −15.6 −17.7 −23.5 −33.3 −36.7 −42.0 −38.5
Net income −10.4 −12.5 −15.6 −17.5 −23.1 −33.6 −32.5 −39.4 −39.7
Growth
EPS, diluted n/a n/a n/a n/a −0.23 −0.23 −5.57 −5.97 −3.38

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−19,972.6%Net margin−20,769.9%Free cash flow margin−15,946.7%Fiscal year 2018Operating margin−18,385.5%Net margin−16,715.5%Fiscal year 2019Operating margin−17,331.5%Net margin−17,291.3%Fiscal year 2020Operating margin−19,678.5%Net margin−19,497.9%Free cash flow margin−18,813.9%Fiscal year 2021Operating margin−26,146.5%Net margin−25,616.0%Free cash flow margin−26,952.6%Fiscal year 2022Operating margin−37,017.8%Net margin−37,378.5%Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −19,972.6% −18,385.5% −17,331.5% −19,678.5% −26,146.5% −37,017.8% n/a n/a n/a
Net margin −20,769.9% −16,715.5% −17,291.3% −19,497.9% −25,616.0% −37,378.5% n/a n/a n/a
Free cash flow margin −15,946.7% n/a n/a −18,813.9% −26,952.6% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−8.0Capital expenditure−0.0Free cash flow−8.0Fiscal year 2018Operating cash flow−11.3Fiscal year 2019Operating cash flow−12.4Fiscal year 2020Operating cash flow−16.9Capital expenditure−0.0Free cash flow−16.9Fiscal year 2021Operating cash flow−24.3Capital expenditure−0.0Free cash flow−24.3Fiscal year 2022Operating cash flow−28.4Fiscal year 2023Operating cash flow−29.1Fiscal year 2024Operating cash flow−28.2Fiscal year 2025Operating cash flow−26.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.0 −11.3 −12.4 −16.9 −24.3 −28.4 −29.1 −28.2 −26.6
Capital expenditure −0.0 n/a n/a −0.0 −0.0 n/a n/a n/a n/a
Free cash flow −8.0 n/a n/a −16.9 −24.3 n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash3.2Shareholders’ equity21.9Fiscal year 2018Cash9.2Shareholders’ equity30.6Fiscal year 2019Cash7.9Shareholders’ equity27.2Fiscal year 2020Cash13.9Shareholders’ equity33.7Fiscal year 2021Cash70.1Shareholders’ equity132.2Fiscal year 2022Cash41.7Shareholders’ equity102.8Fiscal year 2023Cash26.5Shareholders’ equity90.8Fiscal year 2024Cash3.3Shareholders’ equity70.1Fiscal year 2025Cash4.3Shareholders’ equity67.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 3.2 9.2 7.9 13.9 70.1 41.7 26.5 3.3 4.3
Shareholders’ equity 21.9 30.6 27.2 33.7 132.2 102.8 90.8 70.1 67.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2018 30 Sep 2018 FY2019 30 Sep 2019 FY2020 30 Sep 2020 FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023† 30 Sep 2023 FY2024 30 Sep 2024 FY2025† 30 Sep 2025
Revenue and profit
0.1 0.1 0.1 0.1 0.1 0.1 n/a n/a n/a
Growth +50.0% +20.0% +0.0% +0.0% +0.0%
0.1 0.1 n/a n/a n/a n/a n/a n/a n/a
2.9 6.6 8.6 8.8 12.2 17.7 14.8 11.9 9.2
6.1 6.4 6.3 8.1 9.8 11.8 15.3 18.2 18.5
−10.0 −13.8 −15.6 −17.7 −23.5 −33.3 −36.7 −42.0 −38.5
Growth
10.4 12.5 −15.6 −17.5 −23.1 −33.1 −32.0 −38.8 −38.7
n/a n/a n/a 0.0 0.0 0.6 0.6 0.6 1.1
−10.4 −12.5 −15.6 −17.5 −23.1 −33.6 −32.5 −39.4 −39.7
Growth
Per share
n/a n/a n/a n/a −0.23 −0.23 −5.57 −5.97 −3.38
n/a n/a n/a n/a −0.23 −0.23 −5.57 −5.97 −3.38
Growth
n/a n/a n/a n/a 108.6 146.1 6.1 6.7 11.1
n/a n/a n/a n/a 108.6 146.1 6.1 6.7 11.1
Growth +34.5% −95.9% +11.2% +64.5%

† The diluted share count jumps at 2023 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 12.5% a year over five years.
  • Operating margin is down 17,045.2 points on five years ago, at -37,017.8%.
  • A net loss in 9 of 9 years on file.